Jihye Kim
Cheonan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Strategies to overcome chemoresistance in epithelial ovarian cancer: Navigating beyond challenges.
Journal: Critical reviews in oncology/hematology
Published: September 19, 2024
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Journal: Journal of clinical medicine
Published: March 20, 2020
CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: August 25, 2019
Long-term outcomes of single-port laparoscopic myomectomy using a modified suture technique.
Journal: Obstetrics & gynecology science
Published: May 19, 2019
Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study.
Journal: Journal of gynecologic oncology
Published: May 06, 2019
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.
Journal: Genome biology
Published: April 09, 2019
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Journal: Journal of gynecologic oncology
Published: June 18, 2018
Four unreported types of glycans containing mannose-6-phosphate are heterogeneously attached at three sites (including newly found Asn 233) to recombinant human acid alpha-glucosidase that is the only approved treatment for Pompe disease.
Journal: Biochemical and biophysical research communications
Published: December 11, 2017
Significant reduction in allergenicity of ovalbumin from chicken egg white following treatment with ascidian viscera N-acetylglucosaminidase.
Journal: Biochemical and biophysical research communications
Published: April 29, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026